PharmaCyte Biotech (PMCB) Other Non-Current Liabilities (2009 - 2026)
PharmaCyte Biotech (PMCB) recorded Other Non-Current Liabilities of $6.13 million in fiscal Q1 2027 (quarter ended Jul 31, 2026), compared with $458,000 a year earlier and down 44.0% from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
At the end of FY2026 (ended Apr 30, 2026), PharmaCyte Biotech reported Other Non-Current Liabilities of $10.95 million.
- Across earlier fiscal years, Other Non-Current Liabilities came in at $363,000 in FY2025 (-97.2%) and $12.97 million in FY2024.
- Quarterly Other Non-Current Liabilities has ranged from $363,000 in fiscal Q4 2025 to $17.85 million in fiscal Q2 2026 over the past five years.
- On a year-over-year basis, Other Non-Current Liabilities rose in two of the last six quarters, with growth averaging 58.0%.
- Per Business Quant, the preceding three fiscal quarters came in at $10.95 million (Q4 2026), $14.79 million (Q3 2026) and $17.85 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | PharmaCyte Biotech | 4.29 Mn | -68.55 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 6.13 Mn |
| Apr 30, 2026 | 10.95 Mn |
| Jan 31, 2026 | 14.79 Mn |
| Oct 31, 2025 | 17.85 Mn |
| Jul 31, 2025 | 458,000.00 |
| Apr 30, 2025 | 363,000.00 |
| Jan 31, 2025 | 2.38 Mn |
| Oct 31, 2024 | 6.87 Mn |
| Jul 31, 2024 | 9.68 Mn |
| Apr 30, 2024 | 12.97 Mn |
| Jan 31, 2024 | 14.93 Mn |
| Oct 31, 2023 | 15.57 Mn |
| Jul 31, 2023 | 18.88 Mn |
| Oct 31, 2015 | 29,746.00 |
| Jul 31, 2015 | 29,746.00 |
| Apr 30, 2015 | 492,049.00 |
| Apr 30, 2013 | 393,158.00 |
| Jan 31, 2013 | 292,000.00 |
| Oct 31, 2012 | 292,000.00 |
| Apr 30, 2012 | 360,108.00 |
API Access
PharmaCyte Biotech Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();